Details of the Drug

General Information of Drug (ID: DMPXW12)

Drug Name

Monocrotaline

Synonyms

monocrotaline; 315-22-0; Crotaline; Monocrotalin; NSC 28693; CCRIS 416; (-)-Monocrotaline; UNII-73077K8HYV; HSDB 3513; Retronecine cyclic 2,3-dihydroxy-2,3,4-trimethylglutarate; BRN 0048732; (13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione; CHEBI:6980; 14,19-Dihydro-12,13-dihydroxy-20-norcrotolanan-11,15-dione; QVCMHGGNRFRMAD-XFGHUUIASA-N; 73077K8HYV; 20-Norcrotalanan-11,15-dione, 14,19-dihydro-12,13-dihydroxy-, (13alpha,14alpha)-

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C16H23NO6
Canonical SMILES: CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O
InChI: 1S/C16H23NO6/c1-9-13(18)23-11-5-7-17-6-4-10(12(11)17)8-22-14(19)16(3,21)15(9,2)20/h4,9,11-12,20-21H,5-8H2,1-3H3/t9-,11+,12+,15+,16-/m0/s1
InChIKey: QVCMHGGNRFRMAD-XFGHUUIASA-N

Cross-matching ID

PubChem CID: 9415
ChEBI ID: CHEBI:6980
CAS Number: 315-22-0
TTD ID: D0G6AB

References

1	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015